COMMUNIQUÉS West-GlobeNewswire

TRACON Pharmaceuticals Announces Publication of Phase 1b Results for TRC105 in Combination with Inlyta® in Patients with Advanced or Metastatic RCC
10/09/2018
Data Published in Peer-Reviewed Journal, The Oncologist SAN DIEGO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and [...]
Advantis Corp Reports 30% Revenue Rise, Set to Increase Oregon Production by 50%
10/09/2018
NEWPORT BEACH, CA, Sept. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Advantis Corporation (OTC PINK: ADVT) recently released the second quarter financials, posting a thirty percent rise in revenue. The report was [...]
Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology
10/09/2018
Phase 2 data evaluating ZILRETTA ® ( triamcinolone acetonide extended-release injectable suspension) in patients with Type 2 diabetes demonstrated lower blood glucose levels following ZILRETTA injection compared to TAcs [...]
California’s Crucial Role in the Cannabis Retail Market -- CFN Media
10/09/2018
SEATTLE, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Results of interventional study support the use of suPARnostic® Quick Triage in emergency departments
10/09/2018
Press Release Birkerød, 10 September 2018 Today, at the 12 th European Congress of Emergency Medicine in Glasgow, data from the TRIAGE III study were presented, evidencing that use of suPARnostic® Quick Triage shortened [...]
SHIRE ANNOUNCES EARLY RESULTS OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES
10/09/2018
SHIRE ANNOUNCES EARLY RESULTS OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES Dublin, Ireland – September 10, 2018 –Shire plc (LSE: SHP and NASDAQ: SHPG) (“Shire”), Baxalta Incorporated, a [...]
Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis
10/09/2018
Visiopharm Phenomap software presented at the Fluidigm Imaging Mass Cytometry User Group Meeting, expanding the suite of Hyperion Imaging System data analysis tools for translational and clinical research SOUTH SAN [...]
Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 26th CAOCS Canadian Lipid and Bioresource Conference 2018
10/09/2018
WOBURN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]
Sharps Compliance Announces That Montana Will Purchase Medication Disposal Kiosks Via Recently Awarded Partnership for Success Grant
10/09/2018
The Addictive and Mental Disorders Division (AMDD) of the Montana Department of Public Health and Human Services (DPHSS) plans to place 212 medication collection kiosks throughout the state HOUSTON, Sept. 10, 2018 ( [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
10/09/2018
Villepinte (France), le 10 septembre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 [...]
Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules in New CHEST Data Publication
10/09/2018
Independent Study Data Shows Noninvasive Test Could Eliminate the Biopsy Needle, Lower Patient Anxiety and Costs BOULDER, Colo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Biodesix today announced newly published data showing [...]
The American Health Council Names Norman Tomaka, BS, Pharm.MS, FAPhA to its Industry Board
10/09/2018
NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Norman Tomaka, BS, Pharm.MS, FAPhA is named to the American Health Council’s Industry Board. A clinical consultant pharmacist at Consultant Pharmacist Services in Melbourne, [...]
Progressive Care Announces Newly Redesigned Website for Wholly-Owned Subsidiary PharmCo, LLC
10/09/2018
PharmCo’s New Website to Bring More Focus on Robust Offering of Telepharmacy Products and Services MIAMI, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and [...]
Opiant Pharmaceuticals, Inc. and Consort Medical plc Announce Manufacturing Agreement for OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
10/09/2018
SANTA MONICA, Calif., and HEMEL HEMPSTEAD, United Kingdom, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological [...]
Medibio Provides Market Update
10/09/2018
SYDNEY, Australia and MINNEAPOLIS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, today provides a market update to the last [...]
DLT Resolution to Provide Canadian Premier TV Broadcaster Secure Data Digitization Service
10/09/2018
LAS VEGAS, NV , Sept. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - DLT Resolution Inc. (OTC: DLTI) a Distributed Ledger Technology (“Blockchain”) and Information Technology company that services the healthcare and [...]
Emerald Health Therapeutics Named as Cannabis Supplier by Newfoundland Labrador Liquor Corporation to Provide Adult-Use Cannabis Products
10/09/2018
VICTORIA, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has been selected as an authorized cannabis supplier by the Newfoundland Labrador [...]
HempAmericana CEO Issues Letter on Shift to Commercial-Stage Operations
10/09/2018
NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- HempAmericana, Inc.(GlobeNewsWire)—via OTC PR WIRE-- (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, [...]
Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS)
10/09/2018
Demonstrating benefit in rPFS versus control, with no detriment to OS, sufficient for full approval A positive assessment on either rPFS or OS is sufficient for full approval rPFS analysis expected late 2019, [...]

Pages